{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:52:39Z","timestamp":1792320759330,"version":"4.4.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.bpg.2013.08.019","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T03:34:17Z","timestamp":1380252857000},"page":"893-903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cost-effectiveness of Barrett's oesophagus screening and surveillance"],"prefix":"10.1016","volume":"27","author":[{"given":"Louisa G.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C.","family":"Mayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9666","key":"10.1016\/j.bpg.2013.08.019_bib1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(09)60487-6","article-title":"Barrett's oesophagus","volume":"373","author":"Shaheen","year":"2009","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.bpg.2013.08.019_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10080","article-title":"Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling","volume":"10","author":"Garside","year":"2006","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.bpg.2013.08.019_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.gie.2009.06.035","article-title":"Age- and sex-specific yield of Barrett's esophagus by endoscopy indication","volume":"71","author":"Rubenstein","year":"2010","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"10.1016\/j.bpg.2013.08.019_bib4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cgh.2006.03.001","article-title":"Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus","volume":"4","author":"Sharma","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11 Pt 1","key":"10.1016\/j.bpg.2013.08.019_bib5","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1158\/1055-9965.EPI-05-0370","article-title":"Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus","volume":"14","author":"Smith","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.bpg.2013.08.019_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/gut.2007.131375","article-title":"Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus","volume":"57","author":"Whiteman","year":"2008","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.bpg.2013.08.019_bib7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1158\/1055-9965.EPI-07-2852","article-title":"Aspirin, non-steroidal anti-inflammatory drugs, and the risks of cancers of the esophagus","volume":"17","author":"Sadeghi","year":"2008","journal-title":"Cancer epidemiol, Biomarkers Prev"},{"key":"10.1016\/j.bpg.2013.08.019_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1749-6632.2011.06057.x","article-title":"Barrett's esophagus: natural history","volume":"1232","author":"Appelman","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.bpg.2013.08.019_bib9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1572-0241.2008.01835.x","article-title":"Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus","volume":"103","author":"Wang","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.08.019_bib10","series-title":"Guidelines for the diagnosis and management of Barrett\u2019s columnar-lined oesophagus","author":"Watson","year":"2005"},{"issue":"3","key":"10.1016\/j.bpg.2013.08.019_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cgh.2009.10.010","article-title":"Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis","volume":"8","author":"Sikkema","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5 Pt 1","key":"10.1016\/j.bpg.2013.08.019_bib12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0016-5085(89)80011-3","article-title":"Barrett's esophagus: development of dysplasia and adenocarcinoma","volume":"96","author":"Hameeteman","year":"1989","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bpg.2013.08.019_bib13","first-page":"2037","article-title":"The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the cleveland clinic Barrett's esophagus registry","volume":"94","author":"O'Connor","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"7414","key":"10.1016\/j.bpg.2013.08.019_bib14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/bmj.327.7414.534","article-title":"Risk of adenocarcinoma in Barrett's oesophagus: population based study","volume":"327","author":"Murray","year":"2003","journal-title":"BMJ (Clinical Research Ed)"},{"issue":"2","key":"10.1016\/j.bpg.2013.08.019_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00042737-200402000-00008","article-title":"Audit of a Barrett's epithelium surveillance database","volume":"16","author":"Basu","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.bpg.2013.08.019_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00008469-199912000-00010","article-title":"An initial comparison of nine centres registering patients with the UK National Barrett's Oesophagus Registry (UKBOR)","volume":"8","author":"Caygill","year":"1999","journal-title":"Eur J Cancer Prev"},{"issue":"15","key":"10.1016\/j.bpg.2013.08.019_bib17","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1001\/jama.287.15.1972","article-title":"Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review","volume":"287","author":"Shaheen","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.bpg.2013.08.019_bib18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/j.gastro.2012.04.032","article-title":"Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process","volume":"143","author":"Bennett","year":"2012","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.bpg.2013.08.019_bib19","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-2559.2007.02706.x","article-title":"Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists","volume":"50","author":"Kerkhof","year":"2007","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.bpg.2013.08.019_bib20","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1111\/j.1572-0241.2000.03348.x","article-title":"The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression","volume":"95","author":"Skacel","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.bpg.2013.08.019_bib21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/hupa.2001.23510","article-title":"Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation","volume":"32","author":"Montgomery","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.bpg.2013.08.019_bib22","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1136\/bmj.332.7553.1320","article-title":"Improving surveillance for Barrett\u2019s oesophagus","volume":"332","author":"Bampton","year":"2006","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.bpg.2013.08.019_bib23","doi-asserted-by":"crossref","first-page":"312e1","DOI":"10.1053\/j.gastro.2013.05.004","article-title":"Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas","volume":"145","author":"Corley","year":"2013","journal-title":"Gastroenterology"},{"issue":"2 Suppl.","key":"10.1016\/j.bpg.2013.08.019_bib24","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1177\/0272989X9801800209","article-title":"Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis","volume":"18","author":"Stinnett","year":"1998","journal-title":"Med Decis Making"},{"issue":"2","key":"10.1016\/j.bpg.2013.08.019_bib25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0272989X07312474","article-title":"Health technology assessment in the cost-disutility plane","volume":"28","author":"Eckermann","year":"2008","journal-title":"Med Decis Making"},{"issue":"4","key":"10.1016\/j.bpg.2013.08.019_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3322\/CA.2008.0008","article-title":"Economic evaluations of medical care interventions for cancer patients: how, why, and what does it mean?","volume":"58","author":"Shih","year":"2008","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.bpg.2013.08.019_bib27","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/bjs.7599","article-title":"Healthcare resource use and medical costs for the management of oesophageal cancer","volume":"98","author":"Gordon","year":"2011","journal-title":"Br J Surg"},{"issue":"15","key":"10.1016\/j.bpg.2013.08.019_bib28","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett's esophagus","volume":"365","author":"Hvid-Jensen","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.bpg.2013.08.019_bib29","first-page":"670","article-title":"A\u00a0guide for surveillance of patients with Barrett's esophagus","volume":"89","author":"Provenzale","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.bpg.2013.08.019_bib30","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/bjs.7599","article-title":"Health care resource use and medical costs for managing oesophageal cancers","volume":"98","author":"Gordon","year":"2011","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.bpg.2013.08.019_bib31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1365-2036.2001.01004.x","article-title":"Healthcare resource utilization in the management of oesophageal adenocarcinoma","volume":"15","author":"Soni","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.bpg.2013.08.019_bib32","first-page":"1978","article-title":"Factors associated with multiple medication use in different age groups","volume":"43","author":"Moen","year":"2009","journal-title":"Pharmacoepidemiology"},{"issue":"8","key":"10.1016\/j.bpg.2013.08.019_bib33","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s11605-012-1911-9","article-title":"Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high grade dysplasia","volume":"16","author":"Gordon","year":"2012","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"11\u201312","key":"10.1016\/j.bpg.2013.08.019_bib34","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1365-2036.2010.04450.x","article-title":"A\u00a0UK-based cost-utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett's oesophagus","volume":"32","author":"Boger","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.bpg.2013.08.019_bib35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.gie.2008.11.047","article-title":"Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis","volume":"70","author":"Pohl","year":"2009","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.bpg.2013.08.019_bib36","doi-asserted-by":"crossref","first-page":"A215","DOI":"10.1016\/j.jval.2013.03.1089","article-title":"Cost-effectiveness of radiofrequency ablation compared to endoscopic surveillance for patients with Barrett's esophagus with low grade dysplasia","volume":"16","author":"Church","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.bpg.2013.08.019_bib37","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2005"},{"key":"10.1016\/j.bpg.2013.08.019_bib38","series-title":"Decision modelling for health economic evaluation","author":"Briggs","year":"2006"},{"key":"10.1016\/j.bpg.2013.08.019_bib39","series-title":"Principles and practice of screening for disease","author":"Wilson","year":"1968"},{"issue":"3","key":"10.1016\/j.bpg.2013.08.019_bib40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-138-3-200302040-00009","article-title":"Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis","volume":"138","author":"Inadomi","year":"2003","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.bpg.2013.08.019_bib41","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1053\/j.gastro.2009.10.011","article-title":"Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review","volume":"137","author":"Barbiere","year":"2009","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2013.08.019_bib42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cgh.2006.12.022","article-title":"Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett's esophagus","volume":"5","author":"Gerson","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.bpg.2013.08.019_bib43","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1542-3565(04)00394-5","article-title":"Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease","volume":"2","author":"Gerson","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2013.08.019_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1067\/mge.2003.101","article-title":"Cost-effectiveness of screening a population with chronic gastroesophageal reflux","volume":"57","author":"Nietert","year":"2003","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.bpg.2013.08.019_bib45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cgh.2006.12.008","article-title":"Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy","volume":"5","author":"Rubenstein","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2013.08.019_bib46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.gastro.2012.09.060","article-title":"Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus","volume":"144","author":"Benaglia","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2013.08.019_bib47","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.gie.2011.05.001","article-title":"Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis","volume":"74","author":"Gupta","year":"2011","journal-title":"Gastrointest Endosc"},{"issue":"13","key":"10.1016\/j.bpg.2013.08.019_bib48","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jnci\/djr203","article-title":"Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study","volume":"103","author":"Bhat","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.bpg.2013.08.019_bib49","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/gutjnl-2011-300730","article-title":"The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis","volume":"61","author":"Desai","year":"2012","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.bpg.2013.08.019_bib50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1746.2010.06506.x","article-title":"Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations","volume":"26","author":"Hirst","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2013.08.019_bib51","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0029-1214612","article-title":"An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus","volume":"41","author":"Das","year":"2009","journal-title":"Endoscopy"},{"issue":"7","key":"10.1016\/j.bpg.2013.08.019_bib52","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2009.02.062","article-title":"A\u00a0cost-utility analysis of ablative therapy for Barrett's esophagus","volume":"136","author":"Inadomi","year":"2009","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bpg.2013.08.019_bib53","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/j.1572-0241.1999.01276.x","article-title":"Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk","volume":"94","author":"Provenzale","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.bpg.2013.08.019_bib54","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0016-5085(03)00393-7","article-title":"Medical decision analysis of chemoprevention against esophageal adenocarcinoma","volume":"124","author":"Sonnenberg","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bpg.2013.08.019_bib55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2036.2002.01146.x","article-title":"Medical decision analysis of endoscopic surveillance of Barrett's oesophagus to prevent oesophageal adenocarcinoma","volume":"16","author":"Sonnenberg","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.bpg.2013.08.019_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS)\u2013explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcome Res"},{"issue":"5","key":"10.1016\/j.bpg.2013.08.019_bib57","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2753.2006.00754.x","article-title":"Current practice compared with the international guidelines: endoscopic surveillance of Barrett's esophagus","volume":"13","author":"Amamra","year":"2007","journal-title":"J\u00a0Eval Clin Pract"},{"key":"10.1016\/j.bpg.2013.08.019_bib58","first-page":"13","article-title":"Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States","volume":"13","author":"Abrams","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.bpg.2013.08.019_bib59","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1136\/gut.2003.036822","article-title":"The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only\u2013what is the clinical significance?","volume":"53","author":"Meining","year":"2004","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2013.08.019_bib60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0016-5107(99)70339-1","article-title":"Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice","volume":"50","author":"Alikhan","year":"1999","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.bpg.2013.08.019_bib61","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0016-5085(94)90217-8","article-title":"Diagnostic inconsistencies in Barrett's esophagus. Department of veterans affairs gastroesophageal reflux study group","volume":"107","author":"Kim","year":"1994","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2013.08.019_bib62","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1371\/journal.pmed.0040067","article-title":"NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma","volume":"4","author":"Galipeau","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.bpg.2013.08.019_bib63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1479-7364-7-6","article-title":"Development of a cost-effective high-throughput process of microsatellite analysis involving miniaturized multiplexed PCR amplification and automated allele identification","volume":"7","author":"Nguyen","year":"2013","journal-title":"Hum Genomics"},{"issue":"1","key":"10.1016\/j.bpg.2013.08.019_bib64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/path.4212","article-title":"Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer","volume":"231","author":"Budinska","year":"2013","journal-title":"J\u00a0Pathol"},{"issue":"5","key":"10.1016\/j.bpg.2013.08.019_bib65","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.2591","article-title":"Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity","volume":"45","author":"Dulak","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.bpg.2013.08.019_bib66","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1042\/BST0380374","article-title":"Genetic diversity during the development of Barrett's oesophagus-associated adenocarcinoma: how, when and why?","volume":"38","author":"Graham","year":"2010","journal-title":"Biochem Soc Trans"},{"issue":"11","key":"10.1016\/j.bpg.2013.08.019_bib67","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1940-6207.CAPR-10-0108","article-title":"A\u00a0comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma","volume":"3","author":"Merlo","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"10.1016\/j.bpg.2013.08.019_bib68","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MOG.0b013e328362282f","article-title":"Molecular markers for Barrett's esophagus and its progression to cancer","volume":"29","author":"Fels Elliott","year":"2013","journal-title":"Curr Opin Gastroenterol"},{"issue":"2","key":"10.1016\/j.bpg.2013.08.019_bib69","first-page":"49","article-title":"Barrett's esophagus: a review of biology and therapeutic approaches","volume":"5","author":"Kountourakis","year":"2012","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.bpg.2013.08.019_bib70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2036.2005.02536.x","article-title":"The cost-effectiveness of biomarkers for predicting the development of oesophageal adenocarcinoma","volume":"22","author":"Rubenstein","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.bpg.2013.08.019_bib71","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/MEG.0b013e32832183bc","article-title":"Surveillance of Barrett's columnar-lined oesophagus in the UK: endoscopic intervals and frequency of detection of dysplasia","volume":"21","author":"Ramus","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.bpg.2013.08.019_bib72","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1111\/j.1572-0241.2003.08702.x","article-title":"Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis","volume":"98","author":"Corey","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.bpg.2013.08.019_bib73","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1007\/s10620-008-0257-3","article-title":"A\u00a0systematic review and meta-analysis of the treatment for Barrett's esophagus","volume":"53","author":"Li","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2013.08.019_bib74","doi-asserted-by":"crossref","unstructured":"Gordon LG, Mayne GC, Hirst NG, Bright T, Whiteman DC, Australian Cancer Study Clinical Follow-Up Study, Watson DI. Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus. Gastrointest Endosc. Available online 27 September 2013. ISSN 0016-5107. http:\/\/dx.doi.org\/10.1016\/j.gie.2013.07.046. [in press]","DOI":"10.1016\/j.gie.2013.07.046"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691813001844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691813001844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T23:20:01Z","timestamp":1564096801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691813001844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1521691813001844"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2013.08.019","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of Barrett's oesophagus screening and surveillance","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2013.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}